These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Preliminary study of the relation between epidemic erythermalgia and El NiƱo]. Wang XJ Zhonghua Yi Xue Za Zhi; 1988 May; 68(5):266-8, 20. PubMed ID: 3196947 [No Abstract] [Full Text] [Related]
24. Erythromelalgia associated with Clitocybe acromelalga intoxication. Nakajima N; Ueda M; Higashi N; Katayama Y Clin Toxicol (Phila); 2013 Jun; 51(5):451-4. PubMed ID: 23641936 [TBL] [Abstract][Full Text] [Related]
26. [Familial erythermalgia treated with pizotifen]. Guillet MH; Le Noach E; Milochau P; Sassolas B; Guillet G Ann Dermatol Venereol; 1995; 122(11-12):777-9. PubMed ID: 8729824 [TBL] [Abstract][Full Text] [Related]
27. Primary erythermalgia. Report of a patient treated with methysergide maleate. Pepper H JAMA; 1968 Mar; 203(12):1066-7. PubMed ID: 5694372 [No Abstract] [Full Text] [Related]
28. [Case of erythromelalgia due to essential thrombocythemia]. Usukine K; Shinhori H; Idetsuki T; Taoka K; Nakasone H; Kida M; Iki S; Urabe M; Oseto K; Igarashi A Rinsho Ketsueki; 2007 May; 48(5):351-2. PubMed ID: 17571577 [No Abstract] [Full Text] [Related]
29. A patient with adult erythermalgia: evidence suggesting an autoimmune etiology. Jackson AL; Oates JA Am J Med Sci; 2008 Apr; 335(4):320-2. PubMed ID: 18414074 [TBL] [Abstract][Full Text] [Related]
30. Erythromelalgia in essential thrombocythemia is characterized by platelet activation and endothelial cell damage but not by thrombin generation. van Genderen PJ; Lucas IS; van Strik R; Vuzevski VD; Prins FJ; van Vliet HH; Michiels JJ Thromb Haemost; 1996 Sep; 76(3):333-8. PubMed ID: 8883266 [TBL] [Abstract][Full Text] [Related]
32. [Erythromelalgia]. Gylling H; Ikkala E; Rasi V Duodecim; 1987; 103(15):946-8. PubMed ID: 3428195 [No Abstract] [Full Text] [Related]
33. Erythromelalgia in a patient with myelofibrosis. Smelt AH; van der Meer FJ; Meinders AE Neth J Med; 1988 Dec; 33(5-6):243-6. PubMed ID: 3221945 [No Abstract] [Full Text] [Related]
34. Secondary erythermalgia in an HIV-1-positive patient. Dolan CK; Hall MA; Turlansky GW AIDS Read; 2003 Feb; 13(2):91-3. PubMed ID: 12645493 [TBL] [Abstract][Full Text] [Related]
35. Defining a treatable cause of erythromelalgia: acute adolescent autoimmune small-fiber axonopathy. Paticoff J; Valovska A; Nedeljkovic SS; Oaklander AL Anesth Analg; 2007 Feb; 104(2):438-41. PubMed ID: 17242106 [TBL] [Abstract][Full Text] [Related]
36. Erythromelalgia: review of clinical characteristics and pathophysiology. Kurzrock R; Cohen PR Am J Med; 1991 Oct; 91(4):416-22. PubMed ID: 1951386 [TBL] [Abstract][Full Text] [Related]
37. Nitroprusside treatment of erythromelalgia in an adolescent female. Stone JD; Rivey MP; Allington DR Ann Pharmacother; 1997 May; 31(5):590-2. PubMed ID: 9161655 [TBL] [Abstract][Full Text] [Related]
38. [Does erythermalgia of chronic venous insufficiency exist?]. Pistorius MA; Saidi Z; Planchon B J Mal Vasc; 1995; 20(1):60. PubMed ID: 7745363 [No Abstract] [Full Text] [Related]
39. [Erythermalgia: an enigma]. Priollet P J Mal Vasc; 1996; 21(2):78-9. PubMed ID: 8755185 [No Abstract] [Full Text] [Related]
40. Classification and diagnosis of erythromelalgia and erythermalgia. Michiels JJ; Drenth JP; Van Genderen PJ Int J Dermatol; 1995 Feb; 34(2):97-100. PubMed ID: 7737785 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]